Clinical Trial Update: Triple-negative Breast Cancer: a New Perspective on Biomarkers

View source ↗

Summary

A completed clinical trial in Brazil assessing biomarkers in triple-negative breast cancer, presenting new perspectives on biomarker roles.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Instituto Nacional de Cancer, Brazil | Conditions: Triple Negative Breast Neoplasms, Triple Negative Breast Cancer | Status: COMPLETED